Effect of rituximab combined with CVAD regimen on serum VEGF and β 2 -MG levels in patients with primary gastrointestinal B-cell lymphoma

Effect of rituximab combined with CVAD regimen on serum VEGF and β 2 -MG levels in patients with primary gastrointestinal B-cell lymphoma

Objective: To investigate the clinical effect of rituximab combined with CVAD regimen in patients with primary gastrointestinal B-cell lymphoma and serum vascular endothelial growth factor (VEGF) and β2 microglobulin (β2-MG) The impact of the level. Methods: Eighty-four patients with primary gast...

Full description

Bibliographic Details
Main Authors: Shi-Tong Zhang, Ai-Min Wang, Zhi-Hui Sun, Jing-Jing Song, Xiao-Yu Xuan, Wei Liu, Xin-Chun Tian
Format: Article
Language:English
Published: Editorial Board of Journal of Hainan Medical University 2019-12-01
Series:Journal of Hainan Medical University
Subjects:
rituximab
cvad regimen
primary gastrointestinal b-cell lymphoma
short-term efficacy
vascular endothelial growth factor
β 2 microglobulin
Online Access:http://www.hnykdxxb.com/PDF/201912/05.pdf

Internet

http://www.hnykdxxb.com/PDF/201912/05.pdf

Similar Items